Quantum BioPharma Ltd. (CSE:QNTM)

Canada flag Canada · Delayed Price · Currency is CAD
10.56
+0.06 (0.57%)
Jan 8, 2026, 1:44 PM EST
88.24%
Market Cap40.49M
Revenue (ttm)n/a
Net Income (ttm)-39.71M
Shares Out3.83M
EPS (ttm)-14.06
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,428
Average Volume4,069
Open10.33
Previous Close10.50
Day's Range10.21 - 10.56
52-Week Range4.20 - 52.00
Beta0.72
RSI44.21
Earnings DateMar 27, 2026

About Quantum BioPharma

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. It operates through two segments, Biopharmaceutical Innovation and Strategic Investments. The company researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1998
Employees 17
Stock Exchange Canadian Securities Exchange
Ticker Symbol QNTM
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.